Document Detail


Efficacy and Tolerability of Topical 0.05% Flunarizine in Patients With Open-angle Glaucoma or Ocular Hypertension-A Pilot Study.
MedLine Citation:
PMID:  21048514     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
AIM: To evaluate the efficacy and tolerability of flunarizine, a nonselective calcium channel blocker, on intraocular pressure (IOP) in patients with open-angle glaucoma (OAG) or ocular hypertension (OH).
DESIGN: Randomized, placebo-controlled, double blind, cross-over phase II trial.
METHODS: Ten patients diagnosed with bilateral OAG or OH were included. Each patient served as his own control. On the first study visit, 1 drop of either 0.05% flunarizine or placebo was applied in the study eye. Patients were followed-up during 6 hours (0, 15, 30, and 60 min, 2, 3, 4, and 6 h) for vital signs, slit lamp examination, corneal fluorescein staining, and IOP. After a wash-out period of 4 weeks, 1 drop of either placebo or flunarizine was applied in the same eye and patients were followed-up for another 6 hours.
RESULTS: The flunarizine group showed a statistically significant decrease from baseline at T2, T3, T4, and T6 hours (P=0.01, P=0.03, P=0.01, and P=0.03, respectively). No significant difference in IOP decrease from baseline (P>0.06) was observed between the 2 groups. There was no statistically significant difference in all of the following parameters: limbal hyperemia, bulbar or palpebral conjunctival hyperemia, corneal staining with fluorescein, best-corrected visual acuity, comfort of eye drops, and vital signs.
CONCLUSIONS: The absence of a statistically significant difference in IOP reduction between the 2 groups may be due to the small number of patients included. However, a single dose of 0.05% flunarizine significantly reduced IOP when compared with baseline values, whereas this was not observed with placebo.
Authors:
Kaweh Mansouri; Sergio Estrela Silva; Tarek Shaarawy
Related Documents :
10713234 - Latanoprost versus timolol gel to prevent ocular hypertension after phacoemulsification...
24555924 - Prediction of ms disability by multimodal evoked potentials: investigation during relap...
19665744 - Understanding the importance of iop variables in glaucoma: a systematic review.
18794674 - Australia and new zealand survey of antimetabolite and steroid use in trabeculectomy su...
807224 - Clinical and objective assessments of naproxen through 5 years of clinical experience.
18060954 - Sexual function after vaginal surgery for pelvic organ prolapse and urinary incontinence.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Journal of glaucoma     Volume:  20     ISSN:  1536-481X     ISO Abbreviation:  J. Glaucoma     Publication Date:  2011 Oct 
Date Detail:
Created Date:  2011-10-04     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9300903     Medline TA:  J Glaucoma     Country:  United States    
Other Details:
Languages:  eng     Pagination:  519-22     Citation Subset:  IM    
Affiliation:
*Glaucoma Sector, Ophthalmology Clinic, University of Geneva, Geneva, Switzerland †Ophthalmology Clinic, Hospital São João, University of Porto, Porto, Portugal.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Endoscopic Cyclophotocoagulation (ECP) in the Management of Uncontrolled Glaucoma With Prior Aqueous...
Next Document:  Assessment of factors affecting the difference in intraocular pressure measurements between dynamic ...